DE60229848D1 - - und organtransplantationen und unterdrückt apoptose - Google Patents

- und organtransplantationen und unterdrückt apoptose

Info

Publication number
DE60229848D1
DE60229848D1 DE60229848T DE60229848T DE60229848D1 DE 60229848 D1 DE60229848 D1 DE 60229848D1 DE 60229848 T DE60229848 T DE 60229848T DE 60229848 T DE60229848 T DE 60229848T DE 60229848 D1 DE60229848 D1 DE 60229848D1
Authority
DE
Germany
Prior art keywords
organtransplantations
methods
cells
function
suppressing apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60229848T
Other languages
English (en)
Inventor
Fritz H Bach
Edda M Tobiasch
Miguel C Soares
Leo E Otterbein
Jeanne GOSE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ikaria Holdings Inc Clinton Nj Us
Yale University
Beth Israel Deaconess Medical Center Inc
Original Assignee
Yale University
Beth Israel Deaconess Medical Center Inc
Beth Israel Hospital Association
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27404726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60229848(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yale University, Beth Israel Deaconess Medical Center Inc, Beth Israel Hospital Association filed Critical Yale University
Application granted granted Critical
Publication of DE60229848D1 publication Critical patent/DE60229848D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60229848T 2001-06-21 2002-06-21 - und organtransplantationen und unterdrückt apoptose Expired - Lifetime DE60229848D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30028901P 2001-06-21 2001-06-21
US33434001P 2001-11-29 2001-11-29
US33797401P 2001-12-07 2001-12-07
PCT/US2002/019687 WO2003000114A2 (en) 2001-06-21 2002-06-21 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis

Publications (1)

Publication Number Publication Date
DE60229848D1 true DE60229848D1 (de) 2008-12-24

Family

ID=27404726

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229848T Expired - Lifetime DE60229848D1 (de) 2001-06-21 2002-06-21 - und organtransplantationen und unterdrückt apoptose

Country Status (26)

Country Link
US (2) US7238469B2 (de)
EP (2) EP1404811B1 (de)
JP (1) JP4521183B2 (de)
KR (1) KR20040032115A (de)
CN (1) CN100502650C (de)
AT (1) ATE413883T1 (de)
AU (2) AU2002318377B2 (de)
BG (1) BG108492A (de)
BR (1) BR0210599A (de)
CA (1) CA2451266A1 (de)
CY (1) CY1108798T1 (de)
CZ (1) CZ20033448A3 (de)
DE (1) DE60229848D1 (de)
DK (1) DK1404811T3 (de)
ES (1) ES2316583T3 (de)
HK (1) HK1067380A1 (de)
HU (1) HUP0400371A3 (de)
MX (1) MXPA03012031A (de)
NO (1) NO20035637L (de)
NZ (1) NZ562962A (de)
PL (1) PL367544A1 (de)
PT (1) PT1404811E (de)
SG (1) SG147305A1 (de)
SI (1) SI1404811T1 (de)
SK (1) SK15942003A3 (de)
WO (1) WO2003000114A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
PT1404811E (pt) 2001-06-21 2009-01-22 Beth Israel Hospital O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
CN1646140A (zh) * 2002-02-04 2005-07-27 阿尔法玛药品研发有限公司 可释放co的化合物在用于治疗炎症药物的制备中的应用
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
CN100393323C (zh) 2002-02-13 2008-06-11 贝思·伊斯雷尔·迪科尼斯医药中心 治疗血管疾病的方法
CN100496509C (zh) 2002-04-15 2009-06-10 联邦高等教育系统匹兹堡大学 一氧化碳产品及其对于肠梗阻的用途
CN1652802A (zh) 2002-04-15 2005-08-10 联邦高等教育系统匹兹堡大学 治疗坏死性小肠结肠炎的方法
CA2482260A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
CA2485465A1 (en) * 2002-05-17 2003-11-27 Yale University Methods of treating hepatitis
EP1509237A4 (de) * 2002-06-05 2006-07-12 Univ Yale Verfahren zur behandlung von angiogenese, tumorwachstum und metastasen
MXPA04012863A (es) * 2002-06-21 2005-03-31 Univ Pittsburgh Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme.
AU2003283982A1 (en) * 2002-11-07 2004-06-03 University Of Pittsburgh Of The Commonwealth System Of High Education Treatment for hemorrhagic shock
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
AU2004283729A1 (en) * 2003-10-22 2005-05-06 Fred Hutchinson Cancer Research Center Methods, compositions and devices for inducing stasis in cells
EP1552840A1 (de) * 2004-01-07 2005-07-13 Aga Ab Mischung aus Xenon und Kohlenmonoxyd zum Schutz von Zellen
WO2006096774A2 (en) * 2005-03-07 2006-09-14 Sangart, Inc. Composition and methods for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers
WO2007014380A2 (en) 2005-07-27 2007-02-01 University Of North Carolina At Charlotte Composition and method for the restoration and preservation of transplant organs procured from dcd donors
US20070207993A1 (en) * 2005-12-20 2007-09-06 Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
EP2099463B1 (de) 2006-11-07 2014-07-16 The General Hospital Corporation Minderung von vasoaktiver sauerstoffträger-induzierter gefässverengung
WO2010138114A1 (en) 2009-05-27 2010-12-02 Ikaria Holdings, Inc. Devices and methods for engaging indexed valve and pressurized canister assembly with collar and for linear actuation by plunger assembly into fluid communication with device for regulating drug delivery
AU2009202685B1 (en) 2009-06-30 2010-08-19 Ino Therapeutics Llc Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
CA2824056C (en) * 2011-01-14 2019-01-08 Children's Hospital Los Angeles Solution of carbon monoxide for treatment of disease, including sickle cell disease
US8927750B2 (en) 2011-02-04 2015-01-06 Universitaet Zu Koeln Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules
AU2012228972A1 (en) 2011-03-16 2013-10-24 Dynasil Biomedical Corporation Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
EP2717683A4 (de) * 2011-06-10 2015-05-06 Geno Llc Stickoxiddruckbehälter
EP2734235B1 (de) 2011-07-21 2017-03-22 Alfama, Inc. Kohlenmonoxidfreisetzende rutheniummoleküle und ihre verwendungen
US9987302B2 (en) 2011-08-09 2018-06-05 Beth Israel Deaconess Medical Center, Inc. Methods of treating DNA damage
US10667510B2 (en) 2013-03-15 2020-06-02 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
US9629358B2 (en) 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
CN105288599A (zh) * 2015-10-22 2016-02-03 徐州医学院 血红素氧化酶-2在制备抑制器官移植免疫排斥制剂中的应用
CA3073399A1 (en) * 2017-08-25 2019-02-28 Mallinckrodt Hospital Products IP Limited Methods to improve organ viability
EP3524290A1 (de) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Verfahren und system zur überwachung der kohlenmonoxid(co)-verabreichung an ex-vivo-flüssigkeiten
CN116076484A (zh) * 2022-11-30 2023-05-09 武汉大学 一种修复肾脏损伤的低温携氧机械灌注液及其应用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) * 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) * 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
US5180366A (en) * 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) * 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5293875A (en) * 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
CN1245156C (zh) * 1993-02-22 2006-03-15 美国生物科学有限公司 用于体内传送生物制品的方法及用于该方法的组合物
EP0804244A1 (de) 1993-03-26 1997-11-05 Biorelease Technologies, Inc. Häm-proteine enthaltende zusammensetzungen und dazu gehörende methoden
US5763431A (en) * 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
DE4421433C1 (de) 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) * 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) * 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) * 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
ATE265855T1 (de) * 1995-06-30 2004-05-15 Zymogenetics Inc 4-(2-(n-(-2-carboxamidoindole)aminiethyl)- benzensulfonamide oder sulfonylharnstoffe als pdgf antagoniste
ATE331505T1 (de) * 1996-04-05 2006-07-15 Gen Hospital Corp Behandlung einer hämoglobinstörung
US6069132A (en) * 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
WO1998008523A1 (de) 1996-08-27 1998-03-05 Messer Griesheim Gmbh Wasserstoffhaltiges medikament
US6316403B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
WO1998013058A1 (en) * 1996-09-27 1998-04-02 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US5869538A (en) * 1996-11-26 1999-02-09 Research Foundation Of State University Of New York Method for enhancing transport of gases to tissues
FR2757259B1 (fr) * 1996-12-18 1999-03-05 Valeo Thermique Moteur Sa Ailette metallique perfectionnee pour echangeur de chaleur, notamment pour vehicule automobile
US5912019A (en) * 1997-02-07 1999-06-15 Musc Foundation For Research Development Compounds for reducing ischemia/reperfusion injury
TR200101501T2 (tr) 1998-03-16 2002-06-21 Celgene Corporation 2-(2,6-dioksopiperidin-3-il)izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı.
US6203991B1 (en) * 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6558825B1 (en) * 2000-05-12 2003-05-06 Reveo, Inc. Fuel containment and recycling system
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
BR0208012A (pt) * 2001-03-20 2004-03-02 Glaxo Group Ltd Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
WO2002078684A2 (en) 2001-03-30 2002-10-10 Sangstat Medical Corporation Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1395241B9 (de) * 2001-05-25 2005-06-15 Medtronic, Inc. Implantierbare medizinische vorrichtung mit kontrollierter freigabe von gasförmigen mitteln
PT1404811E (pt) * 2001-06-21 2009-01-22 Beth Israel Hospital O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
CN1646140A (zh) * 2002-02-04 2005-07-27 阿尔法玛药品研发有限公司 可释放co的化合物在用于治疗炎症药物的制备中的应用
CN100393323C (zh) * 2002-02-13 2008-06-11 贝思·伊斯雷尔·迪科尼斯医药中心 治疗血管疾病的方法
CN1652802A (zh) * 2002-04-15 2005-08-10 联邦高等教育系统匹兹堡大学 治疗坏死性小肠结肠炎的方法
CN100496509C (zh) * 2002-04-15 2009-06-10 联邦高等教育系统匹兹堡大学 一氧化碳产品及其对于肠梗阻的用途
CA2482260A1 (en) * 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
CA2485465A1 (en) * 2002-05-17 2003-11-27 Yale University Methods of treating hepatitis
EP1509237A4 (de) * 2002-06-05 2006-07-12 Univ Yale Verfahren zur behandlung von angiogenese, tumorwachstum und metastasen
MXPA04012863A (es) * 2002-06-21 2005-03-31 Univ Pittsburgh Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme.
AU2003283982A1 (en) * 2002-11-07 2004-06-03 University Of Pittsburgh Of The Commonwealth System Of High Education Treatment for hemorrhagic shock
US20050255178A1 (en) * 2004-02-04 2005-11-17 Bloch Kenneth D Enhancing the effectiveness of an inhaled therapeutic gas

Also Published As

Publication number Publication date
EP1404811B1 (de) 2008-11-12
PL367544A1 (en) 2005-02-21
ATE413883T1 (de) 2008-11-15
MXPA03012031A (es) 2005-07-01
SI1404811T1 (sl) 2009-04-30
DK1404811T3 (da) 2009-03-02
SG147305A1 (en) 2008-11-28
CZ20033448A3 (cs) 2004-05-12
NO20035637D0 (no) 2003-12-17
AU2002318377B2 (en) 2008-06-19
PT1404811E (pt) 2009-01-22
WO2003000114A9 (en) 2004-05-21
NZ562962A (en) 2009-08-28
BG108492A (en) 2005-02-28
NO20035637L (no) 2004-02-17
CA2451266A1 (en) 2003-01-03
SK15942003A3 (sk) 2004-08-03
CN1545548A (zh) 2004-11-10
HUP0400371A3 (en) 2010-06-28
CY1108798T1 (el) 2014-04-09
KR20040032115A (ko) 2004-04-14
AU2008221551A1 (en) 2008-10-09
HK1067380A1 (en) 2005-04-08
ES2316583T3 (es) 2009-04-16
US7238469B2 (en) 2007-07-03
EP1404811A4 (de) 2006-08-09
WO2003000114A3 (en) 2003-04-10
HUP0400371A2 (hu) 2004-08-30
EP2033514A3 (de) 2009-04-29
CN100502650C (zh) 2009-06-24
JP2005500875A (ja) 2005-01-13
WO2003000114A2 (en) 2003-01-03
BR0210599A (pt) 2004-07-20
US20070202083A1 (en) 2007-08-30
JP4521183B2 (ja) 2010-08-11
EP1404811A2 (de) 2004-04-07
US20030039638A1 (en) 2003-02-27
EP2033514A2 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
DE60229848D1 (de) - und organtransplantationen und unterdrückt apoptose
ECSP066422A (es) Método para obtener factores citotóxicos provenientes de microorganismos, factores citotóxicos obtenidos y composición farmacéutica y conjunto que los contienen.
DK1226233T3 (da) Multipotente voksne stamceller og fremgangsmåder til isolering heraf
MX2009014273A (es) Metodos y composiciones para expansion e implantacion optimizadas de celulas madre mesenquimales.
EP1846548A4 (de) Verfahren zur proliferation von stammzellen
WO2004009767A3 (en) Cell therapy for regeneration
WO2006050330A3 (en) Platelets from stem cells
ATE499098T1 (de) Verwendung von parp-1-hemmern
WO2003012060A3 (en) Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
WO2004096975A3 (en) Apparatus and methods for amplification of blood stem cell numbers
UA88497C2 (ru) Терапевтические композиции кератиноцитарного фактора роста
IL152111A0 (en) Tamandarin and didemnin analogs and methods of making and using them
HK1040983A1 (en) Quinones for treatment of diseases.
DK1185621T3 (da) Overflade til cellekultur
WO2002098361A3 (en) T cell induced tissue repair and regeneration
ATE507290T1 (de) Zellfusionspromotor und dessen nutzung
WO2003078607A3 (en) Tissue specific signal-plexes to dedifferentiate and redifferentiate cells
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
DK1100515T3 (da) Ex vivo-behandling af allogene og xenogene T-celler med pg39-antagonister
ATE258443T1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BETH ISRAEL DEACONESS MEDICAL CENTER, INC., BO, US

Owner name: IKARIA HOLDINGS INC., CLINTON, N.J., US

Owner name: YALE UNIVERSITY, NEW HAVEN, CONN., US

8363 Opposition against the patent